View in EDS HTML Full Text PDF Full Text

Infliximab vs. Adalimumab for Crohn's disease: authors' reply.

Saved in:
Bibliographic Details
Title: Infliximab vs. Adalimumab for Crohn's disease: authors' reply.
Authors: Kaplan, G. G.1 (AUTHOR), Hur, C.2 (AUTHOR), Korzenik, J.3 (AUTHOR), Sands, B. E.4 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Nov2008, Vol. 28 Issue 10, p1266-1267. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/j.1365-2036.2008.03844.x